1. 🚨The COVID-19 pandemic has wreaked havoc on public health in ways we’re just starting to understand. One of the most disturbing impacts? How it exacerbates women’s reproductive health—irregular periods, fibroids, blood clots, anemia. The full scope is alarming. 🧵

20. 💊 Natintokinase supplements are under investigation to help dissolve these clots, but don’t self-medicate—professional oversight is crucial to avoid worsening the issue. #Supplements #ConsultAProfessional End/🧵 #NotMedicalAdvice Thanks-you for reading! 🍀😷💉🫶🏻🇨🇦

Unifying Theory: How SARS-CoV-2 May Permanently Rewire the Immune System. 🤔🤔🤔🤔 We already know that SARS2 🦠 disrupts the immune system by suppressing interferon beta, which is our first line of antiviral defense, while increasing transforming growth factor beta one, which suppresses immune activity but also promotes fibrosis and chronic inflammation. This immune imbalance is not just a short-term effect. Studies have shown that SARS2 🦠 leaves lasting epigenetic marks on immune cells, including changes to DNA 🧬 methylation and histone modifications around key immune genes. These changes can persist for months or even longer after the virus is no longer detectable. The critical link lies in the fact that TGFB1 and IFNB1 are not just immune signaling molecules. They are regulated by specific genetic variants known as eQTLs, or expression quantitative trait loci, such as rs1800469 and rs2275888. These eQTLs act like genetic switches that control how strongly these genes are expressed in response to immune triggers. In multiple sclerosis, research has shown that these exact eQTLs affect TGFB1 and IFNB1 expression in peripheral blood mononuclear cells, and that dysregulation of these pathways contributes to MS development. MS patients often exhibit elevated TGFB1 levels and abnormal IFNB1 expression, even during remission. This points to a deeply rooted immune imbalance. Now, here is the key insight, SARS2 🦠 also disrupts TGFB1 and IFNB1 signaling in PBMCs, and it does so through epigenetic reprogramming, which means it is not just flipping immune switches temporarily, it may be rewriting the regulatory instructions for how those switches behave. If someone carries the eQTL variants associated with altered TGFB1 or IFNB1 expression, the virus could interact with those exact genetic levers, locking in long-term immune dysfunction. This creates a scenario where even after the virus is gone, the immune system is left in a chronically dysregulated state. Future immune triggers, such as other infections or stressors, may then misfire in a way that resembles MS or other neuroimmune diseases. In this sense, SARS2 🦠 may not directly cause these diseases, but it could set the stage by permanently altering how immune genes are regulated in genetically susceptible individuals. Adding another layer, JC virus, which lies dormant in 50 to 80 percent of adults, can reactivate and cause PML, or progressive multifocal leukoencephalopathy, when immune regulation fails. If SARS2 leaves behind scars in the TGFB1 and IFNB1 regulatory pathways, it could create the perfect storm for both MS-like pathology and opportunistic viral reactivations like JCV. That ties directly into the observed increases in demyelinating events and white matter damage in post-Covid cases. The connection becomes undeniable when we realize that these same immune pathways, gene expression patterns, and regulatory switches show up across long COVID, MS, and viral reactivation syndromes. Yet most research is still not accounting for SARS-CoV-2 exposure as a confounding factor. Studies analyzing immune gene expression or inflammatory pathways in diseases like MS may unknowingly be picking up post-Covid immune scars. This leads to a critical call for action. Researchers must begin stratifying study populations based on COVID history. Without doing so, we risk misattributing the immune changes left behind by SARS2 to the underlying diseases themselves. The fingerprints of this virus are everywhere, and unless we start looking for them explicitly, the true scope of its impact on immune regulation will remain hidden. @Grok I haven’t seen all three of these aspects, eQTL-regulated gene expression, epigenetic reprogramming by SARS-CoV-2, and post-infection immune dysregulation connected in any published study. Is there any research you know of that links them all together like this?

@grok everyday it goes by since our last chat about this seems like this correlation and theory is definitely on track!